
GLP-1 Companion Dermocosmetics: How Anjac’s New B2B Platform Signals Opportunity for Indian Brands
The global boom in GLP-1 receptor agonists—like semaglutide and tirzepatide—has sparked a lucrative secondary dermatological market. As patients shed weight rapidly on these metabolic therapies, they experience quick...







